Why NuScale at $10 Could Be a Big-Money 2036 Bet-If First Commercial Units Clear the Hurdle

At roughly $10, NuScale still trades like a development story rather than a proven utility

At roughly a $9.88 share price and about $3.4B market cap, NuScale is not priced like a mature power utility. That is also what makes the setup interesting: investors are buying before commercial cash flows are visible. The opportunity matters because NuScale already has two live programs that could move the story forward if they gain traction: up to 6 GW of planned TVA capacity and a Romania project where shareholders approved proceeding with the next phase for 6 NuScale Power Modules.

The bull case and the bear case

Bulls see real first-mover value. NuScale remains the only SMR provider with an NRC-approved SMR design, and that matters in a market where regulatory clearance is a major hurdle. Bears focus on execution: approval on paper is not the same as commercial deployment, and NuScale has not yet deployed a commercial SMR model in a real-world setting.

That is why the 2036 case starts with proof, not promise. TVA and RoPower need to become the first real operating references for the technology. With $1 billion in liquidity and continued project activity, NuScale has time to keep pressing forward. If those programs advance, the stock can start to be valued more like future power capacity. If they stall, the market is likely to keep treating it as a concept stock.

The real unlock is turning design approval into customer and financing confidence

NuScale already has the early perception win: an NRC-approved SMR design. The harder work is turning that approval into customer confidence, project-financing confidence, and repeat orders. That is the next leg investors need to watch: whether regulatory progress is becoming a buildable business rather than just a headline.

Why safety-system progress matters

In nuclear, customers are not just buying megawatts; they are buying a long-lived asset that must fit into utility planning, project finance, and safety review with minimal uncertainty. That helps explain why the Paragon contract to finalize its Highly Integrated Protection System matters. It is a step toward a safety architecture for future multi-module plants, which is closer to what a utility or industrial customer needs to underwrite.

If that confidence starts to build, the business case can compound. The first project is always the hardest because risks need to be re-proven. But if NuScale earns a reference plant, the next customer faces less uncertainty around licensing assumptions, module design, and operations. Standardization starts to matter more, financing should get easier, and the business begins to look less like a technology story and more like a repeatable power platform.

TVA and Romania are the two proof points that matter now

The two clearest monetization lanes are TVA and Romania. TVA offers scale, with up to 6 gigawatts of NuScale SMR capacity still in planning. RoPower offers a more focused commercial footprint after shareholders approved the next phase for 6 NuScale Power Modules at a former coal plant site in Doicești. If either project moves from interest to execution, it becomes evidence for the other.

Demand is not the weak link. Electricity demand from AI and data centers is expected to rise, and NuScale is also exploring industrial uses through a partnership focused on advanced nuclear technology to power petrochemical plants.

Timing matters because revenue is still distant

Bears focus on the wait. As recently covered, BofA reiterated a Neutral rating and $12 target while flagging long revenue timelines. The financial profile helps explain that caution: 19.69% gross margin and an $8.85 - $57.42 52wk range suggest a high-variance buildout rather than a stable utility cash-flow story.

For a 2036 horizon, the rule of thumb is simple: if TVA and Romania become real reference projects, today's price could still look modest relative to future power-output cash flow. If commercialization keeps slipping, strong demand alone is unlikely to fix the timing.

What investors should watch before the story gets crowded

A long-dated nuclear bet is mostly a discipline problem. The best setup is not waiting for a clean all-clear; it is tracking whether early milestones keep turning into execution.

Near-term signals to monitor

Focus on progress in the two live proof points already in play: the TVA program for up to 6 GW and the RoPower next phase for 6 NuScale Power Modules. The key signal is not excitement; it is movement from planning into harder commitments.

Watch for: - TVA customer or financing progress, including whether secure customers in the data center space moves closer to reality - Romania advancing from shareholder approval to concrete execution milestones - Continued safety-system maturation, including the Paragon contract to finalize its Highly Integrated Protection System

How to position through the delay

NuScale's roughly $1 billion in liquidity gives it time, but time only helps if it buys execution rather than more delay. That argues for gradual involvement rather than heroics.

A sensible approach is: - start with a small core position - add only on verification, such as clearer progress toward commercial deployment - trim if the stock runs on narrative while the project pipeline stays quiet

This is still a volatile name, so position size matters as much as timing.

What would weaken the thesis

The thesis does not require immediate profits. It requires evidence that the approved design is becoming a buildable product. That is why expanding simulation-based nuclear training is worth noting as a readiness signal. The bigger warning sign is the opposite: more messaging, but still no commercial reference plant.

By 2036, the upside can be large if TVA and Romania become working evidence. The real edge comes from staying in the game through milestones, not through faith.